Revenera, a leader in both licensing and compliance, is uniquely positioned to help software producers close the loop – by detecting and responding to piracy, overuse, and misuse through programmatic ...
AAV-based gene therapies hold promise for treating disease, but their long-lasting gene expression limits their use in regenerative medicine. A study now presents DreAM, a drug-inducible AAV system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback